AstraZeneca to establish new vaccines division

Tuesday, 09. November 2021 15:43

COVID-19 vaccine maker AstraZeneca plc confirmed that it would create a new division within the company that will manage business operations related to vaccines and antibody therapies.

"The team will be dedicated to our COVID-19 vaccine, our long-acting antibody combination and our developmental vaccine addressing multiple variants of concern, as well as to our existing portfolio for respiratory viral disease," AstraZeneca was cited by the Financial Times.

According to the report published on Tuesday, the decision means the British company plans to continue marketing its jab co-created with Oxford University, despite rough sales followed by concerns related to the shot's safety.

Related Links: AstraZeneca plc
Baha Breaking the News (BBN) / ND